CENTRAL NERVOUS SYSTEM DISEASES
Clinical trials for CENTRAL NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's drug targets brain inflammation in major trial
Disease control CompletedThis completed Phase 2 study tested whether the drug XPro1595 could help slow cognitive decline in people with early Alzheimer's disease who show signs of brain inflammation. 208 participants with mild Alzheimer's or mild cognitive impairment received either the drug or a placebo…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First look: testing MRI dye safety in babies
Knowledge-focused CompletedThis study aimed to understand how a new contrast agent (a special dye) for MRI scans is processed by the body in very young children. It involved 36 infants under 2 years old who needed an MRI. Researchers gave a single dose and took blood samples to measure how long the agent s…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Guerbet • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC